LEADER 01879oam 2200517I 450 001 9910159451003321 005 20170503085151.0 010 $a1-315-63647-6 010 $a1-317-26513-0 010 $a1-317-26514-9 024 7 $a10.4324/9781315636474 035 $a(CKB)3710000001018886 035 $a(MiAaPQ)EBC4786878 035 $a(OCoLC)968243786 035 $a(PPN)224082396 035 $a(EXLCZ)993710000001018886 100 $a20180706d2017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aDiscourses and counter-discourses on Europe from the Enlightenment to the EU /$fedited by Manuela Ceretta and Barbara Curli 210 1$aLondon ;$aNew York, N.Y. :$cRoutledge,$d2017. 215 $a1 online resource (316 pages) $cillustrations, tables 225 1 $aCritical European Studies ;$v5 311 $a0-367-17370-0 311 $a1-138-64072-7 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $apt. I. Thinking and regretting Europe -- pt. II. The burden of rhetoric : inside the European institutions -- pt. III. Communicating Europe. 410 0$aCritical European studies (London, England) ;$v5. 606 $aPolitical culture$zEurope$xHistory 606 $aPolitical culture$zEuropean Union countries$xHistory 607 $aEurope$xPolitics and government 615 0$aPolitical culture$xHistory. 615 0$aPolitical culture$xHistory. 676 $a341.242/2 701 $aCeretta$b Manuela$0176490 701 $aCurli$b Barbara$0139837 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910159451003321 996 $aDiscourses and counter-discourses on Europe from the Enlightenment to the EU$91993907 997 $aUNINA LEADER 02208nam 2200481 450 001 9910137668803321 005 20221010201921.0 010 $a953-51-4363-8 035 $a(CKB)3230000000077138 035 $a(NjHacI)993230000000077138 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/61066 035 $a(MiAaPQ)EBC30390164 035 $a(Au-PeEL)EBL30390164 035 $a(EXLCZ)993230000000077138 100 $a20221010d2012 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aToxicity and Drug Testing /$fedited by Bill Acree 205 $a1st ed. 210 $cIntechOpen$d2012 210 1$aCroatia :$cIntechOpen,$d2012. 215 $a1 online resource (530 pages) 311 $a953-51-0004-1 330 $aModern drug design and testing involves experimental in vivo and in vitro measurement of the drug candidate's ADMET (adsorption, distribution, metabolism, elimination and toxicity) properties in the early stages of drug discovery. Only a small percentage of the proposed drug candidates receive government approval and reach the market place. Unfavorable pharmacokinetic properties, poor bioavailability and efficacy, low solubility, adverse side effects and toxicity concerns account for many of the drug failures encountered in the pharmaceutical industry. Authors from several countries have contributed chapters detailing regulatory policies, pharmaceutical concerns and clinical practices in their respective countries with the expectation that the open exchange of scientific results and ideas presented in this book will lead to improved pharmaceutical products. 606 $aToxicology 610 $aToxicology 610 $aToxicology and Pharmaceutical Science 610 $aToxinology 610 $aPharmacology 610 $aHealth Sciences 615 0$aToxicology. 676 $a615.9 700 $aWilliam Acree$4auth$01365335 702 $aAcree$b Bill 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910137668803321 996 $aToxicity and Drug Testing$93387141 997 $aUNINA